相关实验视频
Updated: Jul 14, 2025

13:45
Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
10.0K
本质性疾病和功能性蛋白质组学在默克尔细胞多细胞病毒生命周期中的影响
Nathan Lanclos1,2,3, Peter Radulovic1,4, Jackson Bland1
1Department of Molecular Biosciences, College of Arts and Sciences, University of South Florida, Tampa, Florida, USA.
Journal of cellular biochemistry
|October 9, 2023
概括
默克尔细胞多瘤病毒 (MCPyV) 蛋白质表现出内在疾病,可能导致默克尔细胞癌 (MCC) 瘤发生. 这种疾病可能会促进病毒免疫系统逃避,并为这种侵袭性皮肤癌提供新的治疗策略.
科学领域:
- 病毒学 病毒学
- 计算生物学 计算生物学
- 在瘤学瘤学.
背景情况:
- 默克尔细胞多细胞瘤病毒 (MCPyV) 与默克尔细胞癌 (MCC) 有关,这是一种具有增加发病率和高死亡率的侵袭性皮肤癌.
- 了解MCPyV的发病因子对于开发有效的MCC治疗至关重要.
- 在MCPyV蛋白质中内在疾病的作用以前没有被研究过.
研究的目的:
- 通过计算来描述MCPyV蛋白质组内的内在疾病.
- 探索潜在的机制,通过这些机制,内在疾病有助于病毒瘤性.
- 确定MCC的潜在治疗点.
主要方法:
- 对MCPyV蛋白 (LT,ALTO,57kT,sT,VP1) 进行内在疾病的计算分析.
- 功能预测的真核细胞线性图案 (ELMs) 和分子识别特征 (MoRFs).
- 对液态液态相分离 (LLPS) 的倾向的评估.
主要成果:
- 在MCPyV蛋白 LT,ALTO,57kT和VP1中发现了显著的内在障碍,在ST中存在潜在的障碍.
- 疾病倾向与ELM,MoRF和LLPS相关.
- 研究结果表明,MCPyV利用障碍和阶段分离进行致癌活动.
结论:
- 在MCPyV蛋白的内在障碍是病毒瘤发生的一个关键因素.
- MCPyV可能利用失调和阶段凝结来增强病毒功能和免疫逃避.
- 这项研究为实验验证和开发新型MCC疗法提供了基础.
更多相关视频
06:40Temporal Analysis of the Nuclear-to-cytoplasmic Translocation of a Herpes Simplex Virus 1 Protein by Immunofluorescent Confocal Microscopy
Published on: November 4, 2018
6.3K
08:26Purification of Viral DNA for the Identification of Associated Viral and Cellular Proteins
Published on: August 31, 2017
13.7K
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K